Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Cowen & Co. Downgrades Macrogenics to Market Perform

Cowen & Co. Downgrades Macrogenics to Market Perform

Cowen & Co. analyst Boris Peaker downgrades Macrogenics (NASDAQ:MGNX) from Outperform to Market Perform.

byBenzinga Newsdesk

November 22, 2022

1 minute read

Cowen & Co. analyst Boris Peaker downgrades Macrogenics (NASDAQ:MGNX) from Outperform to Market Perform.

Analyst Ratings

The Latest Analyst Ratings for Park Hotels & Resorts

By Benzinga Insights

November 7, 4:00 PM

Analysts have provided the following ratings for Park Hotels & Resorts (NYSE:PK) within the last quarter: Bullish Somewhat…

News

Why Taiwan Semiconductor Manufacturing Company Shares Are Falling

By Henry Khederian

February 6, 11:10 AM

Taiwan Semiconductor Mfg. Co. Ltd. (NYSE: TSM) shares are trading lower by 3.47% to $91.28 Monday morning.

TSM

Enovis Receives FDA Approval Of Patient Specific Instrumentation For STAR Ankle

By Benzinga Newsdesk

December 1, 10:07 AM

Enovis Corporation (NYSE:ENOV), an innovation-driven medical technology company, announced that the U.S. Food and Drug Administration (FDA) has approved the STAR Patient Specific Instrumentation (STAR PSI System)

ENOV

B of A Securities Maintains Buy on Catalent, Lowers Price Target to $125

By Benzinga Newsdesk

August 30, 7:11 AM

B of A Securities analyst Derik De Bruin maintains Catalent (NYSE:CTLT) with a Buy and lowers the price target from $140 to $125.

CTLT

Cowen & Co. Downgrades Macrogenics to Market Perform

Related Posts

The Latest Analyst Ratings for Park Hotels & Resorts

Why Taiwan Semiconductor Manufacturing Company Shares Are Falling

Enovis Receives FDA Approval Of Patient Specific Instrumentation For STAR Ankle

B of A Securities Maintains Buy on Catalent, Lowers Price Target to $125